U.S. ends study of selenium, vitamin E to prevent prostate cancer

10/29/2008 | Washington Post (tiered subscription model), The

U.S. officials have stopped a $119 million study, including more than 35,000 men, of whether vitamin E and selenium protect against prostate cancer, after an analysis showed no risk reduction. The results even suggested a potential harm -- including the risk of diabetes or actually getting prostate cancer.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN